Cargando…
LncRNA HAR1A Suppresses the Development of Non-Small Cell Lung Cancer by Inactivating the STAT3 Pathway
SIMPLE SUMMARY: We found that lncRNA Highly Accelerated Region 1A (HAR1A) was down regulated in NSCLC. Moreover, a 23-gene signature derived from HAR1A-related cancer cell survival genes could predict prognosis and chemotherapy response in LUAD. In vitro experiments indicated that HAR1A suppressed N...
Autores principales: | Ma, Jianqun, Cao, Kui, Ling, Xiaodong, Zhang, Ping, Zhu, Jinhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221461/ https://www.ncbi.nlm.nih.gov/pubmed/35740511 http://dx.doi.org/10.3390/cancers14122845 |
Ejemplares similares
-
LINC00669 promotes lung adenocarcinoma growth by stimulating the Wnt/β‐catenin signaling pathway
por: Zhu, Jinhong, et al.
Publicado: (2023) -
Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma
por: Cao, Kui, et al.
Publicado: (2022) -
LncRNA PVT1 Suppresses the Progression of Renal Fibrosis via Inactivation of TGF-β Signaling Pathway
por: Cao, Lu, et al.
Publicado: (2020) -
Identification and validation of an eight-lncRNA signature that predicts prognosis in patients with esophageal squamous cell carcinoma
por: Zhang, Jinfeng, et al.
Publicado: (2022) -
UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma
por: Zhu, Jinhong, et al.
Publicado: (2021)